We are live on ! Find out more
RT

Robert Torray Torray Investment Partners

AUM $741M
1-Year Est. Return 26.16%
 

Robert Torray is the founder of Torray, a long-standing value-oriented investment firm. Torray strategies have historically emphasized careful stock selection, margin of safety, and multi-year holding periods. The firm remains part of the classic U.S. value-manager set tracked through public disclosures.

This Fund
S&P 500
This Quarter Est. Return
+4.93%
1 Year Est. Return
+26.16%
3 Year Est. Return
+82.37%
5 Year Est. Return
+102.19%
10 Year Est. Return
+343.59%
AUM
$987M
AUM Growth
+$398M
Cap. Flow
+$349M
Cap. Flow %
35.33%
Top 10 Hldgs %
26.42%
Holding
94
New
7
Increased
45
Reduced
9
Closed
3

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$16.4M
2
DHR icon
Danaher
DHR
+$15.6M
3
RTX icon
RTX Corp
RTX
+$15.6M
4
QCOM icon
Qualcomm
QCOM
+$15.4M
5
FISV
Fiserv Inc
FISV
+$15M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$5.4M
2
DD
Du Pont De Nemours E I
DD
+$2.23M
3
GD icon
General Dynamics
GD
+$1.99M
4
WFC icon
Wells Fargo
WFC
+$1.84M
5
JNJ icon
Johnson & Johnson
JNJ
+$1.65M

Sector Composition

Rank Sector Weight
1 Technology 24.29%
2 Healthcare 15.9%
3 Industrials 13.2%
4 Financials 13.04%
5 Energy 10.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BAX icon
1
Baxter International
BAX
$13.6B
$31.3M 3.17%
797,046
+316,265
+66% +$12.7M
EOG icon
2
EOG Resources
EOG
$80.3B
$28.7M 2.9%
245,356
+41,100
+20% +$4.32M
AAPL icon
3
Apple
AAPL
$4.51T
$26.4M 2.67%
1,134,936
+618,560
+120% +$13.2M
DHR icon
4
Danaher
DHR
$154B
$25.9M 2.62%
489,643
+304,348
+164% +$15.6M
QCOM icon
5
Qualcomm
QCOM
$169B
$25.5M 2.58%
321,379
+193,925
+152% +$15.4M
V icon
6
Visa
V
$693B
$25.4M 2.57%
481,816
+313,020
+185% +$16.4M
ENB icon
7
Enbridge
ENB
$110B
$24.9M 2.52%
525,000
+304,560
+138% +$14.4M
RTX icon
8
RTX Corp
RTX
$283B
$24.8M 2.51%
341,386
+212,243
+164% +$15.6M
FISV
9
Fiserv Inc
FISV
$28B
$24.7M 2.5%
819,546
+504,544
+160% +$15M
AMT icon
10
American Tower
AMT
$81.9B
$23.4M 2.37%
259,812
+159,400
+159% +$13.8M
CL icon
11
Colgate-Palmolive
CL
$72.6B
$22.2M 2.25%
326,324
+196,740
+152% +$13.2M
ESRX
12
DELISTED
Express Scripts Holding Company
ESRX
$22.1M 2.23%
318,141
+206,671
+185% +$14.5M
ACN icon
13
Accenture
ACN
$113B
$21.9M 2.21%
270,285
+168,570
+166% +$13.5M
PX
14
DELISTED
Praxair Inc
PX
$21.7M 2.2%
163,565
+100,893
+161% +$13.2M
PCP
15
DELISTED
PRECISION CASTPARTS CORP
PCP
$21.6M 2.19%
85,615
+53,362
+165% +$13.6M
FMC icon
16
FMC
FMC
$1.38B
$21.4M 2.16%
346,174
+224,662
+185% +$14.7M
VFC icon
17
VF Corp
VFC
$5.65B
$20.9M 2.11%
351,984
+223,795
+175% +$13M
BEN icon
18
Franklin Templeton, Inc.
BEN
$17.4B
$20M 2.03%
346,515
+210,170
+154% +$11.5M
CMI icon
19
Cummins
CMI
$80.9B
$19.1M 1.93%
123,823
+74,270
+150% +$11.2M
NKE icon
20
Nike
NKE
$60.5B
$19.1M 1.93%
491,816
+312,790
+175% +$11.6M
APH icon
21
Amphenol
APH
$194B
$19M 1.92%
1,576,080
+932,024
+145% +$11.1M
WFC icon
22
Wells Fargo
WFC
$254B
$18.1M 1.84%
345,200
-36,700
-10% -$1.84M
AKAM icon
23
Akamai
AKAM
$15.9B
$17.6M 1.78%
287,715
+181,040
+170% +$10.1M
BMRN icon
24
BioMarin Pharmaceuticals
BMRN
$12.9B
$17.1M 1.73%
275,185
+210,380
+325% +$12.7M
GILD icon
25
Gilead Sciences
GILD
$181B
$16.5M 1.67%
198,464
+126,045
+174% +$9.81M
1
2 3 4

Similar funds

LGA
Lebenthal Global Advisors Hauppauge, New York $741M AUM 22.36% 1-Year Est. Return
SIC
SFE Investment Counsel Los Angeles, California $742M AUM 39.38% 1-Year Est. Return
CPC
Consolidated Planning Corp Atlanta, Georgia $742M AUM 25.54% 1-Year Est. Return
NC
Northcape Capital Sydney, Australia $742M AUM 2.34% 1-Year Est. Return
TWM
Tolleson Wealth Management Dallas, Texas $742M AUM 17.39% 1-Year Est. Return
WIC
Wilkins Investment Counsel Boston, Massachusetts $742M AUM 23.98% 1-Year Est. Return
NCA
Newbrook Capital Advisors New York $741M AUM 78.82% 1-Year Est. Return
TPM
Triasima Portfolio Management Montreal, Quebec, Canada $740M AUM 69.74% 1-Year Est. Return

Robert Torray's Q2 2014 Portfolio in Review

As of Q2 2014, Robert Torray held 94 positions worth $987M, up 67% from $590M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Robert Torray deployed $349M of net new capital in Q2 2014, opening 7 new positions and adding to 45 existing holdings. Its largest new stake was DIRECTV COM STK (DE): 120,200 shares worth $10.2M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Du Pont De Nemours E I, an estimated $2.23M trimmed.

  • Robert Torray's largest Q2 2014 buy was DIRECTV COM STK (DE): 120,200 shares worth $10.2M.
  • Robert Torray added most to Visa in Q2 2014, an estimated $16.4M increase.
  • Robert Torray's biggest Q2 2014 reduction was Du Pont De Nemours E I, cutting an estimated $2.23M.
  • Robert Torray fully exited Vertex Pharmaceuticals in Q2 2014, selling an estimated $5.4M.
  • Robert Torray's ten largest holdings make up 26% of its $987M portfolio in Q2 2014.
  • Robert Torray opened 7 new positions and closed 3 in Q2 2014.
  • Robert Torray's portfolio value rose 67% quarter-over-quarter to $987M.

Based on Torray Investment Partners's 13F filing for Q2 2014, filed 14 Aug 2014.